Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082152 | Drug Discovery Today: Disease Models | 2013 | 5 Pages |
Abstract
To enable the widespread use of zebrafish larvae in drug discovery, it is required to define drug concentration at the target site and to assess metabolites at a resolution necessary for in vivo pharmacology screening. These questions are now being investigated using mass spectroscopy and contribute to our understanding of how the outcome of zebrafish toxicity, safety and efficacy studies can translate to rodent and human data.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
H. Diekmann, A. Hill,